6505--FY26QTR4 OPTUM HAZARDOUS DRUG COMPOUNDING, TOMS RIVER, NJ (VA-26-00071687)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs intends to award a firm fixed price, sole source contract to Optum Pharmacy 801, Inc. for the compounding and delivery of hazardous drugs to the NJHCS Toms River, NJ facility. The contract requires preparation of chemotherapy prescriptions pursuant to valid electronic orders signed and verified by credentialed VA providers and pharmacists, adhering to established pharmacy guidelines and regulatory standards including USP 797 and USP 800, as well as FDA insanitary guidelines. The compounded products must be packaged and shipped with strict compliance to manufacturers’ requirements for drug stability and refrigeration and delivered to the facility by 8:00 am on the day of treatment. Additionally, products must be compatible with Equishield closed system transfer devices and include preferred VA tubing for administration. The contract covers a range of hazardous drugs with specific estimated quantities, including agents like Azacitidine, Bortezomib, Carboplatin, and others, along with necessary dispensing fees and related supplies. This sole source procurement follows federal regulations allowing for non-competitive contract award under FAR 13.105(a), and while other potential sources may submit capability statements for consideration by June 17, 2026, they must meet stringent requirements including credentialing and shipping standards. The notice emphasizes prohibition of gray market products and clarifies that information submitted by interested parties will not incur reimbursement and briefings will not be provided. The contract is managed through the VA’s Network Contract Office with Morgan Weeks serving as the primary contracting officer.
General Info
Agency
NAICS
Place of Performance
NYSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The prescriptions will be prepared pursuant to a valid order electronically signed by a VA provider credentialled to prescribe HD drugs and verified by a VA pharmacist. The prescription will be faxed to Optum by 11:30 am on the day prior to the intended treatment appointment. The chemotherapy prescription will be compounded according to recognized pharmacy regulatory guidelines. Contractor shall provide shipping in accordance with manufacturers requirements for drug stability and refrigeration. The packaging will have all required labeling to identify the contents of the packages as hazardous. Contractor shall deliver the final product to the Toms River facility no later than 8:00am the day of treatment. Contractor shall comply with USP 797 and USP 800 and FDA insanitary guideline regulations and prepare HD drugs using aseptic technique. The final product will be compatible with the Equishield closed system transfer devices and Optum will attach VA Toms River Clinic preferred tubing for administration. Drug Name Unit Estimated Quantity Azacitidine Inj 100mg EA 10 Bortezomib Inj 3.5mg EA 7 Carboplatin Inj Sol 600mg/60mL EA 7 Cisplatin Inj Sol 100mg/100ml EA 7 Cyclophosphamide Inj 500mg sdv EA 4 Dispensing Fee - Exact Volume Req EA 12 Dispensing Fee - Facility Patient EA 12 Irinotecan 100mg SDV EA 10 Oxaliplatin 100mg SDV EA 10 Carfilzomib 60mg SDV EA 6 Docetaxel 80mg EA 8 Gemcitabine 2GM/52.6ml EA 4 Pemetrexed 500MG SDV EA 10 Trastuzumab 150MG SDV EA 6 Fluorouracil 5G SDV EA 10 Etoposide 500MG SDV EA 8 Doxorubicin 200MG SDV EA 8 Vincristine 2MG SDV EA 4 Mesna 100MG SDV EA 6 Brentuximab 50MG SDV EA 4 Connector LL FC-1 EA 70 Dextrose 5% Inj 250mL EA 25 Dextrose 5% Inj 500mL EA 5 Dextrose 5% Inj 50mL Multi EA 12 Ext Set 19" 0.2mic Smtsite 20350E EA 20 Homepump C 270ml 10ml/hr C270100 EA 1 Homepump C 270ml 2ml/hr C270020 EA 2 Homepump C 270ml 5ml/hr C270050 EA 5 Set 126" Alaris LS 20dp 24260007 EA 30 Set 127" Alaris LS 20dp 10015861A EA 40
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a). The Department of Veterans Affairs, New Jersey locations intends to issue a sole source award contract to OPTUM PHARMACY 801, INC., all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. Please note, you MUST have a credentialled to prescribe HD drugs and verified by a VA pharmacist and be able to meeting the shipping/delivery requirements above. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored. NAICS Code: 325412 Pharmaceutical Preparation Manufacturing
Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on June 17, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.